## Abstract Neuroleptic malignant syndrome is the rarest and the most serious of the neuroleptic induced movement disorders. Although potent neuroleptics are more frequently associated with NMS, atypical antipsychotic drugs may also be a cause of NMS. Three databases were searched using the terms β
β¦ LIBER β¦
Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia
β Scribed by Ashish Srivastava; Hirabai A. Borkar; Sumitkumar Chandak
- Book ID
- 108962360
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 42 KB
- Volume
- 63
- Category
- Article
- ISSN
- 1323-1316
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Olanzapine induced neuroleptic malignant
β
AleΕ‘ Kogoj; Ingrid Velikonja
π
Article
π
2003
π
John Wiley and Sons
π
English
β 79 KB
Clozapine-induced neuroleptic malignant
β
Franco Benazzi
π
Article
π
1999
π
John Wiley and Sons
π
English
β 66 KB
Clozapine-induced neuroleptic malignant syndrome not recurring with olanzapine, a structurally and pharmacologically similar antipsychotic
Padlock in Scrotum in a Patient with Par
β
Sergio Merino-Salas; Miguel Angel Arrabal-Polo; Fernando Lopez-Carmona Pintado;
π
Article
π
2011
π
Springer US
π
English
β 145 KB
Neuroleptic malignant syndrome during ha
β
Keiko Tanaka; Tatsuo Akechi; Mitsuo Yamazaki; Ryuichi Hayashi; Yutaka Nishiwaki;
π
Article
π
1998
π
Springer-Verlag
π
English
β 54 KB
Postoperative neuroleptic malignant synd
β
NAOHISA TSUCHIYA; ERI MORIMURA; TETSUJI HANAFUSA; TETSUTARO SHINOMURA
π
Article
π
2007
π
John Wiley and Sons
π
English
β 436 KB
Ziprasidone-related neuroleptic malignan
β
Nicola S. Gray
π
Article
π
2004
π
John Wiley and Sons
π
English
β 45 KB
## Abstract A case of neuroleptic malignant syndrome (NMS) in a patient with Parkinson's disease (PD) is presented. The syndrome was precipitated by the atypical antipsychotic, ziprasidone. The challenge of recognizing NMS in a patient with underlying parkinsonian symptoms, where prominent symptom